Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

UK dividends calendar - next 7 days

5th Nov 2026 14:28

Read More

IN BRIEF: Convatec hires former Fortrea, Labcorp and GSK exec as CFO

3rd Nov 2026 09:59

Convatec Group PLC - London-based medical products, including Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care - Hires Jill McConnell to be chief financial officer, replacing Fiona Ryder. McConnell will join the company on January 1 and take over as CFO and board director on March 1 after the release of Convatec's 2026 results on February 23. Convatec notes that McConnell brings more than 25 years of finance experience, most recently serving as CFO of New York-listed clinical research firm Fortrea Holdings Inc, with previous senior roles at Labcorp Holdings Inc and GSK PLC. At Convatec, McConnell will lead Finance, Corporate Strategy & Development, Convatec Business Services and Investor Relations, reporting to Chief Executive Officer Jonny Mason. Back in July, Convatec had said Ryder would step down as CFO, having been in post since the start of 2022. Read More

WINNERS & LOSERS: Drax jumps on AI deal, AB Foods falls on outlook

3rd Nov 2026 09:50

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

LONDON BRIEFING: Coca-Cola Europacific sales up; Shell sells LNG stake

3rd Nov 2026 08:00

(Alliance News) - Coca-Cola Europacific Partners reports higher third-quarter revenue and reaffirms its full-year outlook on Tuesday. Shell agrees to sell its stake in an Australian liquefied natural gas project for USD1.45 billion, while Convatec announces the appointment of a new chief financial officer. Read More

CORRECT: New board chairs for Adsure, EDX, Mpac and Pulsar

2nd Nov 2026 21:54

(This version provides the correct headquarters of Mpac Group PLC. The high-speed packaging and automation solutions company is based in Coventry.) Read More

EXECUTIVE CHANGES: New board chairs for Adsure, EDX, Mpac and Pulsar

2nd Nov 2026 13:09

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: Berenberg cuts Haleon, Barclays cuts Dr Martens

2nd Nov 2026 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON BROKER RATINGS: Haleon hit with price target cuts by 7 brokers

30th Oct 2026 09:46

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BROKER RATINGS: Morgan Stanley raises Aviva; Jefferies cuts GSK

29th Oct 2026 10:06

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Monday: Read More

LONDON MARKET OPEN: FTSE 100 up as Shell surges; ECB, US data to come

29th Oct 2026 08:48

(Alliance News) - Stock prices in London opened higher on Thursday, with gains for oil major Shell helping the FTSE 100 advance, but earnings for banking firm Lloyds failed to inspire. Read More

LONDON BRIEFING: Shell profit doubles; Lloyds earnings jump

29th Oct 2026 07:51

(Alliance News) - Lloyds Banking Group reports a sharp rise in third-quarter profit, while Shell more than doubles its earnings and announces a USD5 billion share buyback. Premier Inn owner Whitbread expects to benefit from UK budget measures limiting business rates increases for hospitality businesses. Read More

LONDON MARKET CLOSE: Eyes on Fed call as markets "tolerate" UK budget

28th Oct 2026 17:01

(Alliance News) - Stocks in London ended mixed on Wednesday as investors assessed Chancellor John Healey's first budget and looked ahead to an expected US interest rate hold. Read More

LONDON MARKET MIDDAY: FTSE 100 slips ahead of budget but banks rally

28th Oct 2026 12:12

(Alliance News) - Stock prices in London were mixed at midday on Wednesday, with the FTSE 100 edging lower ahead of Chancellor John Healey's first budget, though banking stocks rallied on a report that a planned tax increase on the sector would be less severe than feared. Read More

WINNERS & LOSERS: Standard Chartered rises on outlook, Hunting slumps

28th Oct 2026 10:31

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday. Read More

GSK beats expectations but Shingrix and Arexvy miss weighs on Vaccines

28th Oct 2026 09:40

(Alliance News) - GSK PLC on Wednesday reported better-than-expected earnings, largely driven by improved margins and lower costs, although sales growth was limited by a weaker-than-hoped performance in its Vaccines division. Read More

LONDON MARKET OPEN: FTSE 100 dips ahead of UK budget, Fed decision

28th Oct 2026 09:09

(Alliance News) - Stock prices in London opened lower on Wednesday, as investors braced for Chancellor John Healey's first budget and the US Federal Reserve's interest rate decision, while losses for GSK and Unilever weighed on the FTSE 100. Read More

LONDON BRIEFING: Unilever lifts outlook; GSK profit falls

28th Oct 2026 07:56

(Alliance News) - GSK reports a fall in third-quarter profit despite higher revenue, while Unilever upgrades its full-year volume growth outlook. Aston Martin narrows its third-quarter loss as revenue jumps, driven by deliveries of its Valhalla supercar. Read More

GSK gets positive results in drug trials for rectal and ovarian cancer

26th Oct 2026 09:19

(Alliance News) - GSK PLC has announced positive results from tests of its drug candidates for rectal and ovarian cancer. Read More

LONDON BRIEFING: Computacenter lifts outlook, Plus500 upbeat

26th Oct 2026 07:58

(Alliance News) - Computacenter raises its full-year profit outlook after strong third-quarter trading, while Plus500 forecast annual revenue and earnings ahead of market expectations. GSK has reported positive clinical trial results for two cancer treatments. Read More

GSK hails five-year ViiV Healthcare data on HIV treatment Cabenuva

21st Oct 2026 16:22

(Alliance News) - GSK PLC on Wednesday noted five-year data for ViiV Healthcare's HIV treatment Cabenuva, which the lead study author found "highly encouraging". Read More

FTSE 100 Latest
Value10,673.94
Change-108.72